Search research articles
Contact Us
Filters
Showing results (131-140 of 156) with videos related to
Page
of 16
Sort By:
Pharmaceutics
|
September 28, 2024
Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg
Klervi Golhen, Michael Buettcher, Jörg Huwyler, et al.
Pediatric Rheumatology Online Journal
|
January 22, 2026
Evaluation of adalimumab tapering regimens in children and adolescents with juvenile idiopathic arthritis in remission: a simulation study
Dominic S Bräm, Verena Gotta, Gilbert Koch, et al.
Clinical Pharmacokinetics
|
February 14, 2020
Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
Paola Mian, Karel Allegaert, Sigrid Conings, et al.
Clinical and Translational Science
|
November 3, 2025
Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis
Venkateswari Y Muthukrishnan, Thomas Kerbusch, Laura E Strong, et al.
BMC Medical Research Methodology
|
December 9, 2017
Validity of mobile electronic data capture in clinical studies: a pilot study in a pediatric population
Belinda von Niederhäusern, Ramon Saccilotto, Sabine Schädelin, et al.
The Journal of Antimicrobial Chemotherapy
|
May 14, 2025
Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study
Yulia Butscheid, Pascal M Frey, Marc Pfister, et al.
Archives of Disease in Childhood
|
May 12, 2021
Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates
Samira Samiee-Zafarghandy, Tamara van Donge, Gerhard Fusch, et al.
Clinical Pharmacokinetics
|
August 5, 2021
Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model
David Ternant, Marc Pfister, Olivier Le Tilly, et al.
Frontiers in Medicine
|
May 19, 2023
Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves' disease
Britta Steffens, Gilbert Koch, Pascal Gächter, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 12, 2021
Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study
Gilbert Koch, Britta Steffens, Stephanie Leroux, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 156) with videos related to
Sort By:
Page
of 16
Pharmaceutics
|
September 28, 2024
Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg
Klervi Golhen, Michael Buettcher, Jörg Huwyler, et al.
Pediatric Rheumatology Online Journal
|
January 22, 2026
Evaluation of adalimumab tapering regimens in children and adolescents with juvenile idiopathic arthritis in remission: a simulation study
Dominic S Bräm, Verena Gotta, Gilbert Koch, et al.
Clinical Pharmacokinetics
|
February 14, 2020
Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
Paola Mian, Karel Allegaert, Sigrid Conings, et al.
Clinical and Translational Science
|
November 3, 2025
Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis
Venkateswari Y Muthukrishnan, Thomas Kerbusch, Laura E Strong, et al.
BMC Medical Research Methodology
|
December 9, 2017
Validity of mobile electronic data capture in clinical studies: a pilot study in a pediatric population
Belinda von Niederhäusern, Ramon Saccilotto, Sabine Schädelin, et al.
The Journal of Antimicrobial Chemotherapy
|
May 14, 2025
Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study
Yulia Butscheid, Pascal M Frey, Marc Pfister, et al.
Archives of Disease in Childhood
|
May 12, 2021
Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates
Samira Samiee-Zafarghandy, Tamara van Donge, Gerhard Fusch, et al.
Clinical Pharmacokinetics
|
August 5, 2021
Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model
David Ternant, Marc Pfister, Olivier Le Tilly, et al.
Frontiers in Medicine
|
May 19, 2023
Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves' disease
Britta Steffens, Gilbert Koch, Pascal Gächter, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 12, 2021
Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study
Gilbert Koch, Britta Steffens, Stephanie Leroux, et al.
Page
of 16